Contribution of COMT and BDNF Genotype and Expression to the Risk of Transition from Acute to Chronic Low Back Pain
Date
2020Journal
Clinical Journal of PainPublisher
Lippincott Williams and WilkinsType
Article
Metadata
Show full item recordAbstract
Objectives: A number of factors, including heritability and the environment, contribute to risk of transition from acute low back pain (ALBP) to chronic low back pain (CLBP). The aim of this study was to A) compare somatosensory function and pain ratings at LBP onset between the ALBP and CLBP conditions and (B) evaluate associations between BDNF and COMT polymorphisms and expression levels at LBP onset to acute and chronic pain burden and risk for transition to the chronic pain state. Methods: In this longitudinal study, 220 participants were enrolled following recent onset of LBP and data was collected until the LBP resolved or until the end of the study at six months. Forty-two participants' pain resolved prior to 6 weeks from onset and 42 participants continued to have pain at 6 months. Patient reported pain burden, somatosensory function (quantitative sensory testing) and blood samples were collected at each study visit. Results: CLBP is associated with greater pain burden and somatosensory hypersensitivity at the time of LBP onset. COMT rs4680 genotype (GG) was associated with acute cold pain sensitivity and with the risk for transition to CLBP while COMT expression was independently associated with risk for transition. Discussion: CLBP was characterized by higher reported pain burden and augmented hypersensitivity at LBP onset. COMT expression and genotype were associated with acute pain burden and likelihood of transition to CLBP.Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85080099694&doi=10.1097%2fAJP.0000000000000819&partnerID=40&md5=56d19dca7b49920e79591059c0cf1afa; http://hdl.handle.net/10713/12182ae974a485f413a2113503eed53cd6c53
10.1097/AJP.0000000000000819
Scopus Count
Collections
Related articles
- Contribution of Endocannabinoid Gene Expression and Genotype on Low Back Pain Susceptibility and Chronicity.
- Authors: Ramesh D, D'Agata A, Starkweather AR, Young EE
- Issue date: 2018 Jan
- A Role for Global DNA Methylation Level and IL2 Expression in the Transition From Acute to Chronic Low Back Pain.
- Authors: Eller OC, Glidden N, Knight B, McKearney N, Perry M, Bernier Carney KM, Starkweather A, Young EE, Baumbauer KM
- Issue date: 2021
- Genetic contribution of catechol-O-methyltransferase variants in treatment outcome of low back pain: a prospective genetic association study.
- Authors: Omair A, Lie BA, Reikeras O, Holden M, Brox JI
- Issue date: 2012 May 21
- Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
- Authors: Margarit C, Roca R, Inda MD, Muriel J, Ballester P, Moreu R, Conte AL, Nuñez A, Morales D, Peiró AM
- Issue date: 2019 Nov
- The COMT rs4680 Met allele contributes to long-lasting low back pain, sciatica and disability after lumbar disc herniation.
- Authors: Jacobsen LM, Schistad EI, Storesund A, Pedersen LM, Rygh LJ, Røe C, Gjerstad J
- Issue date: 2012 Aug